Animal models of asthma: value, limitations and opportunities for alternative approaches
Animal models of asthma: value, limitations and opportunities for alternative approaches
Asthma remains an area of considerable unmet medical need. Few new drugs have made it to the clinic during the past 50 years, with many that perform well in preclinical animal models of asthma, failing in humans owing to lack of safety and efficacy. The failure to translate promising drug candidates from animal models to humans has led to questions about the utility of in vivo studies and to demand for more predictive models and tools based on the latest technologies. Following a workshop with experts from academia and the pharmaceutical industry, we suggest here a disease modelling framework designed to better understand human asthma, and accelerate the development of safe and efficacious new asthma drugs that go beyond symptomatic relief.
659-670
Holmes, Anthony M
fb0c6a4b-703f-43bd-a2aa-4c8d8298bc5b
Solari, Roberto
5afc272f-dd7e-4f4a-b046-3758c9bbfaad
Holgate, Stephen T.
2e7c17a9-6796-436e-8772-1fe6d2ac5edc
23 June 2011
Holmes, Anthony M
fb0c6a4b-703f-43bd-a2aa-4c8d8298bc5b
Solari, Roberto
5afc272f-dd7e-4f4a-b046-3758c9bbfaad
Holgate, Stephen T.
2e7c17a9-6796-436e-8772-1fe6d2ac5edc
Holmes, Anthony M, Solari, Roberto and Holgate, Stephen T.
(2011)
Animal models of asthma: value, limitations and opportunities for alternative approaches.
Drug Discovery Today, 16 (15-16), .
(doi:10.1016/j.drudis.2011.05.014).
(PMID:21723955)
Abstract
Asthma remains an area of considerable unmet medical need. Few new drugs have made it to the clinic during the past 50 years, with many that perform well in preclinical animal models of asthma, failing in humans owing to lack of safety and efficacy. The failure to translate promising drug candidates from animal models to humans has led to questions about the utility of in vivo studies and to demand for more predictive models and tools based on the latest technologies. Following a workshop with experts from academia and the pharmaceutical industry, we suggest here a disease modelling framework designed to better understand human asthma, and accelerate the development of safe and efficacious new asthma drugs that go beyond symptomatic relief.
This record has no associated files available for download.
More information
Published date: 23 June 2011
Organisations:
Clinical & Experimental Sciences
Identifiers
Local EPrints ID: 194685
URI: http://eprints.soton.ac.uk/id/eprint/194685
ISSN: 1359-6446
PURE UUID: dada40d7-28ee-4e93-a496-6246d180d31d
Catalogue record
Date deposited: 09 Aug 2011 14:27
Last modified: 14 Mar 2024 04:00
Export record
Altmetrics
Contributors
Author:
Anthony M Holmes
Author:
Roberto Solari
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics